Citations

Clear

9383 citation(s) found for "Thomas, PS".

O2‐03‐01: Insight into the mechanism of gamma‐secretase cleavage: Juxtamembrane amino acids are key to the length of secreted amyloid beta peptide
Kukar, Thomas , Ladd, Thomas B., Robertson, Paul , Jansen‐West, Karen , Eggert, Simone , Koo, Edward H. , Golde, Todd E. , Moore, Brenda D.

Mayo Clinic

Alzheimer's & Dementia | July 11, 2010 | Volume: 6 | Issue: 4S_Part_3 | Pages: No page available

10.1016/j.jalz.2010.05.314 Get It

P3‐287: Surface plasmon resonance binding kinetics of Alzheimer's disease amyloid β peptide capturing‐ and plaque binding‐monoclonal antibodies
Poduslo, Joseph F., Ramakrishnan, Muthu, Wengenack, Thomas M., Howell, Kyle G., Kandimalla, Karunya K.

Mayo Clinic

Alzheimer's & Dementia | July 11, 2010 | Volume: 6 | Issue: 4S_Part_17 | Pages: No page available

10.1016/j.jalz.2010.05.1787 Get It

P3‐251: Magnetic resonance biomarkers of neurodegeneration in a transgenic mouse model of Alzheimer's disease
Chamberlain, Ryan , Preboske, Gregory M., Polk, Avery , Kotilinek, Linda, Wengenack, Thomas M., Poduslo, Joseph F., Youdas, S.A., Marjańska, Małgorzata , Ashe, Karen H. , Garwood, Michael , Jack, Clifford R.

Mayo Clinic

Alzheimer's & Dementia | July 11, 2010 | Volume: 6 | Issue: 4S_Part_17 | Pages: No page available

10.1016/j.jalz.2010.05.1751 Get It

P1‐433: Brain volume changes with divalproex sodium in Alzheimer's disease
Fleisher, Adam , Weiner, Michael W. , Truran, Diana , Mai, Jacqueline, Aisen, Paul , Thomas, Ronald G. , Schneider, Lon S. , Tariot, Pierre N. , Jack, Clifford R. , Cummings, Jeffrey L.

Mayo Clinic

Alzheimer's & Dementia | July 11, 2010 | Volume: 6 | Issue: 4S_Part_10 | Pages: No page available

10.1016/j.jalz.2010.05.988 Get It

IC‐P‐044: Longitudinal Imaging Changes and Vascular Risk Factors: A 10‐1Year Study
Penman, Alan D. , Coker, Laura H., Mosley, Thomas H., Knopman, David S. , Catellier, Diane , Shibata, Dean , Mosley, Thomas H.

Mayo Clinic

Alzheimer's & Dementia | July 11, 2010 | Volume: 6 | Issue: 4S_Part_1 | Pages: No page available

10.1016/j.jalz.2010.05.058 Get It

How to Organize a Fellowship Program: Lessons Learned and How to Include Accreditation Council for Graduate Medical Education Competencies in the Curriculum
Collichio, Frances A. , Kosty, Michael P., Moynihan, Timothy J. , Davis, Thomas, Stewart, James A.

Mayo Clinic

Journal of Clinical Oncology | July 7, 2010 | Volume: 28 | Issue: 22 | Pages: 3659-3667

10.1200/jco.2010.28.1964 | PMID 20606079 Get It

Reply to C. Barker et al and H. Asai et al
Nowakowski, Grzegorz S. , Maurer, Matthew J. , Witzig, Thomas E. , Cerhan, James R. , Maurer, Matthew

Mayo Clinic

Journal of Clinical Oncology | June 22, 2010 | Volume: 28 | Issue: 24 | Pages: e427-e428

10.1200/jco.2010.28.9710 Get It

Calculating alveolar capillary conductance and pulmonary capillary blood volume: comparing the multiple- and single-inspired oxygen tension methods
Ceridon, Maile L., Beck, Kenneth C., Olson, Thomas P. , Bilezikian, Jordan A. , Johnson, Bruce D.

Mayo Clinic

Journal of Applied Physiology | June 11, 2010 | Volume: 109 | Issue: 3 | Pages: 643-653

10.1152/japplphysiol.01411.2009 | PMID 20538842 Get It

Key elements for determining alveolar-capillary membrane conductance (Dm) and pulmonary capillary blood volume (Vc) from the lung diffusing capacity (Dl) for carbon monoxide (DlCO) or for nitric oxide (DlNO) are the reaction rate of carbon monoxide with hemoglobin (θCO) and the DmCO/DlNOrelationship (α-ratio). Although a range of values have been reported, currently there is no consensus regarding these parameters. The study purpose was to define optimal parameters (θCO, α-ratio) that would experimentally substantiate calculations of Dm and Vc from the single-inspired O2tension [inspired fraction of O2(FiO2)] method relative to the multiple-FiO2method. Eight healthy men were studied at rest and during moderate exercise (80-W cycle). Dm and Vc were determined by the multiple-FiO2and single-FiO2methods (rebreathe technique) and were tabulated by applying previously reported θCOequations (both methods) and by varying the α-ratio (single-FiO2method) from 1.90 to 2.50. Values were then compared between methods throughout the examined α-ratios. Dm and Vc were critically dependent on the applied θCOequation. For the multiple-FiO2method, Dm was highly variable between θCOequations (rest and exercise); the range of Vc was less widespread. For the single-FiO2method, the θCOequation by Reeves and Park (1992) combined with an α-ratio between 2.08 and 2.26 gave values for Dm and Vc that most closely matched those from the multiple-FiO2method and were also physiologically plausible compared with predicted values. We conclude that the parameters used to calculate Dm and Vc values from the single-FiO2method (using DlCOand DlNO) can significantly influence results and should be evaluated within individual laboratories to obtain optimal values.
Angiomatoid fibrous histiocytoma in a 25-year-old male
Mansfield, Aaron S. , Larson, Brenda, Stafford, Scott L., Shives, Thomas C., Haddock, Michael G. , Dingli, David , Mansfield, Aaron S , Dingli, David

Mayo Clinic

Rare Tumors | June 8, 2010 | Volume: 2 | Issue: 2 | Pages: 54-56

10.4081/rt.2010.e20 | PMID 21139823 Get It

Angiomatoid fibrous histiocytoma (AFH) is a rare disease that is often misdiagnosed initially. Patients can present with a clinical picture concerning for other diseases, and pathologic review is not always revealing. Molecular diagnostics are increasingly being utilized to detect gene fusions characteristic for AFH. Surgery remains the mainstay of management, and can effectively control local recurrences and metastases. Herein we describe a case report of a 25-year-old gentleman whose presentation was concerning for lymphoma. Subsequently we review of the relevant literature.
Alvimopan for the Management of Postoperative Ileus After Bowel Resection: Characterization of Clinical Benefit by Pooled Responder Analysis
Viscusi, Eugene R. , Wolff, Bruce G., Delaney, Conor P. , Senagore, Anthony J. , Techner, Lee, LUDWIG, KIRK A.

Mayo Clinic

World Journal of Surgery | June 4, 2010 | Volume: 34 | Issue: 9 | Pages: 2185-2190

10.1007/s00268-010-0635-9 | PMID 20526599 Get It

AbstractBackgroundA pooled post hoc responder analysis was performed to assess the clinical benefit of alvimopan, a peripherally acting mu‐opioid receptor (PAM‐OR) antagonist, for the management of postoperative ileus after bowel resection.MethodsAdult patients who underwent laparotomy for bowel resection scheduled for opioid‐based intravenous patient‐controlled analgesia received oral alvimopan or placebo preoperatively and twice daily postoperatively until hospital discharge or for 7 postoperative days. The proportion of responders and numbers needed to treat (NNT) were examined on postoperative days (POD) 3–8 for GI‐2 recovery (first bowel movement, toleration of solid food) and hospital discharge order (DCO) written.ResultsAlvimopan significantly increased the proportion of patients with GI‐2 recovery and DCO written by each POD (P < 0.001 for all). More patients who received alvimopan achieved GI‐2 recovery on or before POD 5 (alvimopan, 80%; placebo, 66%) and DCO written before POD 7 (alvimopan, 87%; placebo, 72%), with corresponding NNTs equal to 7.ConclusionsOn each POD analyzed, alvimopan significantly increased the proportion of patients who achieved GI‐2 recovery and DCO written versus placebo and was associated with relatively low NNTs. The results of these analyses provide additional characterization and support for the overall clinical benefit of alvimopan in patients undergoing bowel resection.